N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer

Background: The N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) is the only writer responsible for DNA 6mA modifications. At present, its role in cancer is still unclear, and further systematic pan-cancer analysis is needed to explore its value in diagnosis, prognosis and immunological functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mingqi, Zhu, Jiajie, Ye, Yingquan, Li, Ping, Sun, Weijie, Zhang, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373955/
https://www.ncbi.nlm.nih.gov/pubmed/37437243
http://dx.doi.org/10.18632/aging.204868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373955/
https://www.ncbi.nlm.nih.gov/pubmed/37437243
http://dx.doi.org/10.18632/aging.204868

Ejemplares similares